Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma - Concepedia

Concepedia

Publication | Open Access

Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma

DOI Full Paper Access

45

Citations

28

References

2022

Year

Hironori Ochi, Masayuki Kurosaki, Kouji Joko, Toshie Mashiba, Nobuharu Tamaki, Kaoru Tsuchiya, Hiroyuki Marusawa, Toshifumi Tada, Shinichiro Nakamura, Ryoichi Narita,

Hepatology Research

Abstract

Pretreatment NLR is a simple tool for routine measurement in clinical practice. It can predict PFS in patients with unresectable HCC treated with atezolizumab plus bevacizumab, especially mALBI grade 1 or 2a.

References

	Year	Citations

Page 1